Paradoxical reactions to targeted biological treatments: A way to treat and trigger?

Acta Derm Venereol. 2010 Mar;90(2):183-5. doi: 10.2340/00015555-0777.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abatacept
  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Products / adverse effects*
  • Colitis, Ulcerative / drug therapy*
  • Etanercept
  • Female
  • Humans
  • Immunoconjugates / adverse effects
  • Immunoglobulin G / adverse effects
  • Infliximab
  • Male
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / pathology
  • Pyoderma Gangrenosum / chemically induced*
  • Pyoderma Gangrenosum / drug therapy
  • Pyoderma Gangrenosum / pathology
  • Receptors, Tumor Necrosis Factor

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Biological Products
  • Immunoconjugates
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Abatacept
  • Infliximab
  • Etanercept
  • efalizumab